AnPac Bio-Medical Science Co., Ltd. Gains 29.87%

Thu, Apr 28, 2022 at 05:34 PM

AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ) soared at $0.4, a gain of 29.9%. The stock appeared on our News Catalysts scanner on Mon, Apr 04, 2022 at 07:42 AM in the 'PRIVATE PLACEMENT' category. From Thu, Apr 14, 2022, the stock recorded 12.50% Up Days and 22.22% Green Days

The stock spiked on Tue, Apr 12, 2022 at $0.55 with a volume of 1M+.

About AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ)

AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative, patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence.

Top 10 Gainers:

Statera Biopharma Inc. (STAB:NASDAQ), 81.87%
Swvl Holdings Corp (SWVL:NASDAQ), 50.15%
RCM Technologies, Inc. (RCMT:NASDAQ), 44.57%
Color Star Technology Co Ltd (CSCW:NASDAQ), 35.44%
SQZ Biotechnologies Company (SQZ:NYSE), 34.66%
AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 29.87%
Werewolf Therapeutics Inc. (HOWL:NASDAQ), 26.49%
Ra Medical Systems, Inc. (RMED:NYSE), 26.4%
Archer Aviation Inc. Class A (ACHR:NYSE), 25.14%
Pitney Bowes Inc. (PBI:NYSE), 23.43%